Other languages NexImmune, Inc.

Equities

NEXI

US65344D2080

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-26 pm EDT			5-day change	1st Jan Change
3.37 ^USD	-1.17%		-3.44%	+51.80%

Apr. 17	North American Morning Briefing : Stock Futures -2-	DJ
Apr. 16	NexImmune, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NexImmune, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 16
NexImmune, Inc. Announces Executive Changes	Apr. 05
Top Premarket Decliners	Jan. 04
Top Premarket Decliners	Dec. 04
Wall Street Set to Open Lower Friday as Investors Await Economic Data, Powell Speech	Dec. 01
Top Premarket Gainers	Dec. 01
Investors Look Ahead to Powell Speech as US Futures Trend Lower Friday	Dec. 01
NexImmune, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 17
Top Premarket Decliners	Nov. 06
Top Premarket Decliners	Nov. 03
NexImmune Extends Partnership With Yale, JDRF for Type 1 Diabetes	23-10-24
NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes	23-10-24
Sector Update: Health Care Stocks Softer Late Afternoon	23-10-18
Sector Update: Health Care Stocks Sliding Wednesday Afternoon	23-10-18
NexImmune Implements 1-for-25 Reverse Stock Split	23-10-18
NexImmune Cutting Over Half of Workforce to Fund Development of Novel Therapeutic Candidates	23-08-31
NexImmune, Inc. Announces Executive Changes, Effective as of September 2, 2023	23-08-31
NexImmune, Inc. Announces Workforce Reduction to Enable Continued AIMTM Nanoparticle Platform Development Strategy	23-08-31
NexImmune, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10
Neximmune Announces Initial Positive Data from the NEXI-001 Phase 1 Trial for Relapsed/Refractory Post Allo-Hsct Aml At the American Society of Clinical Oncology 2023 Annual Meeting	23-06-05

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages NexImmune, Inc.

Equities

NEXI

US65344D2080

Other languages

Filters